Volcon announces launch of proposed public offering

Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering
Vertical Aerospace (Vertical) (NYSE: EVTL) ("Vertical" or the "Company"), a global aerospace and technology company that is pioneering electric aviation, today announced that it has commenced an underwritten public offering of $75 million of units (the "Offering").
Volcon, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering
AUSTIN, TX / ACCESS Newswire / February 5, 2025 / Volcon, Inc. (NASDAQ:VLCN) (the "Company"), the first all-electric, off-road
Nuvectis Pharma prices 2.7M shares at $5.00 in underwritten public offering
Nuvectis Pharma (NVCT) announced the pricing of its previously announced underwritten public offering of 2,700,000 shares of its common stock at a
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” public offering of approximately 2.
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
Nuvectis intends to use the net proceeds from the offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital expenditures, costs of operating as a public company and other general corporate purposes.
Volcon announces public offering of warrants and common shares
Volcon (NASDAQ:VLCN) has commenced a public offering, including common shares (or pre-funded warrants in lieu thereof) and warrants to purchase shares of common stock. The net proceeds from the offering will be used for general corporate and working capital needs.
Morningstar6d
Immunome Announces Proposed Public Offering of Common Stock
In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public ...
Nasdaq7d
Akero Therapeutics Announces Pricing of Upsized Public Offering for $350 Million
Akero Therapeutics announced a public offering of over 5.3 million shares at $48 each, aiming for $350 million in proceeds. Akero Therapeutics, Inc. has announced a public offering of 5,333,420 ...
When Did Facebook (Meta) Go Public?
Facebook (Meta) had one of the largest and most anticipated IPOs in history on May 18, 2012, but it failed to meet expectations. A NASDAQ glitch cost investors.
Investing6d
Immunome stock tumbles after public offering pricing
Investing.com -- Immunome, Inc. (NASDAQ:IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnology company ...
Morningstar8d
Akero Therapeutics Announces Proposed Public Offering of Common Stock
In addition, Akero intends to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of shares of its common stock at the public offering price, less underwriting ...